Williams Timothy's most recent trade in Pros Holdings Inc was a trade of 11,262 Restricted Stock Units done . Disclosure was reported to the exchange on May 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pros Holdings Inc | Timothy V. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 11,262 | 11,262 | - | - | Restricted Stock Units | |
| Pros Holdings Inc | Timothy V. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.87 per share. | 08 May 2025 | 6,125 | 130,179 (0%) | 0% | 16.9 | 103,329 | Common Stock |
| Pros Holdings Inc | Timothy V. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2025 | 6,125 | 0 | - | - | Restricted Stock Units | |
| Vanda Pharmaceuticals Inc | Timothy Williams | SVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.76 per share. | 01 Mar 2025 | 26,941 | 294,884 (0%) | 0% | 4.8 | 128,239 | Common Stock |
| Vanda Pharmaceuticals Inc | Timothy Williams | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 125,000 | 321,825 (0%) | 0% | 0 | Common Stock | |
| Pros Holdings Inc | Timothy V. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2024 | 7,205 | 0 | - | - | Restricted Stock Units | |
| Pros Holdings Inc | Timothy V. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.63 per share. | 11 May 2024 | 7,205 | 126,936 (0%) | 0% | 30.6 | 220,689 | Common Stock |
| Pros Holdings Inc | Timothy V. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2024 | 6,125 | 6,125 | - | - | Restricted Stock Units | |
| Pros Holdings Inc | Timothy V. Williams | Director | Sale of securities on an exchange or to another person at price $ 31.03 per share. | 11 May 2024 | 2,882 | 124,054 (0%) | 0% | 31.0 | 89,428 | Common Stock |
| Vanda Pharmaceuticals Inc | Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 4.18 per share. | 04 Mar 2024 | 8,941 | 196,825 (0%) | 0% | 4.2 | 37,396 | Common Stock |
| Vanda Pharmaceuticals Inc | Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 4.41 per share. | 04 Mar 2024 | 8,147 | 205,766 (0%) | 0% | 4.4 | 35,917 | Common Stock |
| Vanda Pharmaceuticals Inc | Williams Timothy | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 125,000 | 213,913 (0%) | 0% | 0 | Common Stock | |
| Vanda Pharmaceuticals Inc | Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 6.56 per share. | 13 Jun 2023 | 14,600 | 88,913 (0%) | 0% | 6.6 | 95,754 | Common Stock |
| Pros Holdings Inc | Timothy V. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 7,205 | 7,205 | - | - | Restricted Stock Units | |
| Pros Holdings Inc | Timothy V. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 6,809 | 0 | - | - | Restricted Stock Units | |
| Pros Holdings Inc | Timothy V. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.98 per share. | 11 May 2023 | 6,809 | 122,795 (0%) | 0% | 25.0 | 170,089 | Common Stock |
| Pros Holdings Inc | Timothy V. Williams | Director | Sale of securities on an exchange or to another person at price $ 24.61 per share. | 11 May 2023 | 3,064 | 119,731 (0%) | 0% | 24.6 | 75,405 | Common Stock |
| Vanda Pharmaceuticals Inc | Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 6.24 per share. | 02 Mar 2023 | 8,437 | 111,814 (0%) | 0% | 6.2 | 52,685 | Common Stock |
| Vanda Pharmaceuticals Inc | Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 6.25 per share. | 02 Mar 2023 | 8,301 | 103,513 (0%) | 0% | 6.3 | 51,887 | Common Stock |
| Vanda Pharmaceuticals Inc | Timothy Williams | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 77,500 | 77,500 | - | - | Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Timothy Williams | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 32,700 | 120,251 (0%) | 0% | 0 | Common Stock | |
| Vanda Pharmaceuticals Inc | Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 10.21 per share. | 15 Aug 2022 | 4,611 | 95,551 (0%) | 0% | 10.2 | 47,065 | Common Stock |
| Vanda Pharmaceuticals Inc | Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 10.42 per share. | 15 Aug 2022 | 3,689 | 100,162 (0%) | 0% | 10.4 | 38,439 | Common Stock |
| Pros Holdings Inc | Timothy V. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 6,809 | 6,809 | - | - | Restricted Stock Units | |
| Pros Holdings Inc | Timothy V. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2022 | 4,388 | 0 | - | - | Restricted Stock Units | |
| Pros Holdings Inc | Timothy V. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.23 per share. | 12 May 2022 | 4,388 | 118,180 (0%) | 0% | 24.2 | 106,321 | Common Stock |
| Pros Holdings Inc | Timothy V. Williams | Director | Sale of securities on an exchange or to another person at price $ 24.91 per share. | 12 May 2022 | 2,194 | 115,986 (0%) | 0% | 24.9 | 54,653 | Common Stock |
| Vanda Pharmaceuticals Inc | Timothy Williams | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 77,500 | 77,500 | - | - | Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Timothy Williams | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 32,700 | 115,911 (0%) | 0% | 0 | Common Stock | |
| Vanda Pharmaceuticals Inc | Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 11.09 per share. | 28 Feb 2022 | 12,060 | 103,851 (0%) | 0% | 11.1 | 133,779 | Common Stock |
| Vanda Pharmaceuticals Inc | Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 16.15 per share. | 16 Aug 2021 | 3,715 | 83,211 (0%) | 0% | 16.1 | 59,989 | Common Stock |
| Pros Holdings Inc | Timothy V. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 4,388 | 4,388 | - | - | Restricted Stock Units | |
| Pros Holdings Inc | Timothy V. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 4,811 | 0 | - | - | Restricted Stock Units | |
| Pros Holdings Inc | Timothy V. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.37 per share. | 29 Apr 2021 | 4,811 | 116,198 (0%) | 0% | 44.4 | 213,464 | Common Stock |
| Pros Holdings Inc | Timothy V. Williams | Director | Sale of securities on an exchange or to another person at price $ 43.72 per share. | 29 Apr 2021 | 2,406 | 113,792 (0%) | 0% | 43.7 | 105,190 | Common Stock |
| Vanda Pharmaceuticals Inc | Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 17.85 per share. | 05 Mar 2021 | 5,400 | 86,926 (0%) | 0% | 17.9 | 96,390 | Common Stock |
| Vanda Pharmaceuticals Inc | Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 17.88 per share. | 05 Mar 2021 | 200 | 92,326 (0%) | 0% | 17.9 | 3,576 | Common Stock |
| Vanda Pharmaceuticals Inc | Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 18.60 per share. | 01 Mar 2021 | 11,856 | 100,200 (0%) | 0% | 18.6 | 220,543 | Common Stock |
| Vanda Pharmaceuticals Inc | Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 18.54 per share. | 01 Mar 2021 | 7,674 | 92,526 (0%) | 0% | 18.5 | 142,307 | Common Stock |
| Vanda Pharmaceuticals Inc | Timothy Williams | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 77,500 | 77,500 | - | - | Employee Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Timothy Williams | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 32,700 | 112,056 (0%) | 0% | - | Common Stock |